Novo Nordisk A/S (NVO NYSE) stock market data APIs
$37.7668
0.15(0.4%)
as of April 10, 2026
Try our APIs with
free plan!
Novo Nordisk A/S Financial Data Overview
Price chart is built with
Anychart
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Prev. Close
37.7668
Open
37.9213
High
38.0681
Low
37.7656
52 wk Range
34.5818-77.6835
Market Cap
167 441 M
P/E Ratio
10.4513
Shares Outstanding
3 363 M
Revenue
309 064 M
EPS
6.04
Dividends (Yield)
0.048
Beta
0.272
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Novo Nordisk A/S (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novo Nordisk A/S data using free add-ons & libraries
Get Novo Nordisk A/S Fundamental Data
Novo Nordisk A/S Fundamental data includes:
- Net Revenue: 309 064 M
- EBITDA: 153 295 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-03
- EPS/Forecast: 5.9
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novo Nordisk A/S News
New
A Look At Hims & Hers (HIMS) Valuation After GLP 1 Crackdown And Wegovy Pivot
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The regulatory halt of Hims...
India GLP 1 Generics Test Novo Nordisk Pricing Power And Valuation
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cheap semaglutide generics have launched in India following local loss of exclusivity for N...
Inhaled drug developer Avalyn files for U.S. IPO
aprott Avalyn Pharma (AVLN [https://seekingalpha.com/symbol/AVLN]), a biotech focused on developing inhaled therapeutics for the lung disorder pulmonary fibrosis, has filed paperwork with the SEC for...
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
Quick Read Eli Lilly (LLY) reported Q4 revenue of $19.29B up 42.6% YoY, with Mounjaro generating $7.41B (up 110%) and Zepbound adding $4.26B (up 123%). Novo Nordisk (NVO) posted Q4 revenue down 7.6% ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
